The lack of demand for shares post interim read-out confirms management's prudence and skill in getting that CR away for $20M at 30c a share. Happy to sit for the next up wave, confident in the knowledge that the Company has a strong balance sheet, with funding through to Trial completion.
Ann: Investor Presentation, page-107
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.005(1.39%) |
Mkt cap ! $200.8M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 35.5¢ | $175.6K | 484.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 64913 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 64169 | 4 |
View Market Depth
| Last trade - 11.03am 19/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |